16q22-24 DNA amplification specifically predicts and mediates, through MAF gene, breast cancer bone metastasis.

A Chromatin Immunoprecipitation Approach Based on BAC Transgenesis

A549 cells before/after NME2 induction

Analysis of expression and epigenetic changes in human colorectal cancer and matching mucosa tissues

BC ChIP-on-chip in SW480, array A

CREB3L1 is a metastasis suppressor that represses expression of genes regulating metastasis, invasion and angiogenesis

Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation

Cell-type-specific target selection by combinatorial binding of Smad2/3 and hepatocyte nuclear factor 4-alpha in HepG2 cells

Cereblon expression is required for the anti-myeloma activity of lenalidomide and pomalidomide

ChIP-chip analysis of human DREAM complex subunits in G0-arrested and S-phase synchronized cells

ChIP-chip analysis of transcription factors GABP, SRF, TAF, and NRSF on Affymetrix whole genome tiling arrays 2.0R

ChIP-chip for histone modifications in hESCs and differentiated hESCs

ChIP-chip from HCT116 cells with UbH2B and H3K4me2 coupled to expression analysis

ChIP-chip from ex-vivo differentiated erythroblasts derived from human primary CD34+ cells

ChIP-chip of 38 nuclear receptors and NR co-factors in breast cancer cell line MCF7

ChIP-chip of 6 chromatin marks (FAIRE, H3K4me1, H3K4me3, H3K27me3, H3R17me2, H3AZAce) in breast cancer cell line MCF7

ChIP-on-Chip data from Rh30 cells +/- rapamycin treatment

ChIP-on-chip of H2A variants and H3 from normal Prostate epithelial cells (PrEC) and the LNCaP cancer cell line

Characterization of the transcriptional roles of NME2

Classical Hodgkin lymphoma shows epigenetic features of an abortive plasma cellular differentiation